This inventor holds 12 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Historx, Inc., Novartis Ag. Active years: 2011-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Glastonbury, CT (US) (2011 - 2016)
- Carlsbad, CA (US) (2015 - 2019)
Company Filing History:
Years Active: 2011-2019
Title: Innovative Contributions of Jason Christiansen
Introduction
Jason Christiansen, an accomplished inventor based in Glastonbury, CT, is known for his significant contributions to the field of cancer diagnostics. With a total of 12 patents to his name, he has been at the forefront of developing innovative methods that assist in quantifying biomarker expressions in cancer patients.
Latest Patents
Jason’s latest patents include groundbreaking technologies such as "Quantitative methods and kits for providing reproducible IHC4 scores." This technology focuses on assessing the risk of disease recurrence in cancer patients by utilizing standardized quantitative evaluations of biomarker expression. Key biomarkers in this evaluation include estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 (Ki67). Such innovative methods empower caretakers to make informed decisions regarding the most effective treatment routes for their patients.
In addition, he has developed a method for "Reproducible quantification of biomarker expression," which emphasizes obtaining accurate scores for biomarker expression in tissue samples. This method is designed to produce reliable results regardless of the instrument used, its location, or the operator, thus enhancing the reliability of cancer diagnostics across various clinical settings.
Career Highlights
Throughout his career, Jason has worked with notable companies, including Historx, Inc. and Novartis AG. His tenure at these organizations has allowed him to refine his innovative approaches and push the boundaries of what is possible in cancer treatment and diagnostics. His collective experiences have greatly enriched the biomedical landscape.
Collaborations
In his professional journey, Jason has collaborated with esteemed colleagues such as Robert Pinard and Gregory R Tedeschi. Together, they have contributed to advancements in the field, harnessing their expertise to further explore and develop critical diagnostic techniques.
Conclusion
Jason Christiansen's contributions to cancer research and diagnostics underscore the importance of innovation in medicine. His patents not only reflect his ingenuity as an inventor but also highlight the potential for improved patient outcomes through enhanced diagnostic tools. As he continues to forge ahead in his work, the medical community can look forward to the fruits of his labor impacting patient care positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile